Naviscan Announces Partnership With Tecnologie Avanzate for Italian Market
- PEM Now Available as Tool to Help Italian Women in the Fight against Breast Cancer
SAN DIEGO, May 3, 2011 /PRNewswire/ -- Naviscan, Inc., the leader in 3D Molecular Breast Imaging (MBI), has entered into a distribution agreement with Tecnologie Avanzate s.r.l. to market and service Naviscan's high-resolution organ-specific PET scanner in Italy. The agreement represents the introduction of PEM (Positron Emission Mammography), the scanner's breast application, as a new tool available to Italian women in their fight against breast cancer.
Naviscan manufactures the only commercially-available PEM scanner and PEM-guided biopsy system. The scanner uses PET technology to produce tomographic images that allow physicians to visualize breast tumors down to 2 mm, the width of a grain of rice. In recently published data, PEM has been found to be significantly more precise at identifying benign and cancerous lesions, in what scientists call "specificity", therefore reducing the number of unnecessary biopsies. This finding is a welcomed outcome for women and physicians looking for ways to reduce the patient trauma and cost associated with unnecessary procedures.
Tecnologie Avanzate and its partners have specialized in high tech medical equipment in the fields of nuclear imaging, radiation therapy and breast imaging since 1959 and is the exclusive distributor for Hologic(R) and TomoTherapy(R) products. The Naviscan PET scanner is an ideal complement to Tecnologie Avanzate's breast and nuclear imaging expertise and an ideal partner to continue its expansion in Europe.
About Naviscan, Inc.
Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PET scanner is currently installed and available in breast and imaging centers throughout the U.S. and other parts of the world. The Company is headquartered in San Diego, California and is the first to obtain FDA-clearance for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance. For more information, call +1-858-587-3641 or visit http://www.naviscan.com
Share this article